BioLife Solutions Inc (BLFS)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	-66,427	-102,234	-83,419	-146,098	-139,805	-106,361	-95,965	-15,211	-8,908	4,025	2,813	-21,443	1,983	7,778	19,180	39,812	-1,657	16,293	-18,441	-49,039
Total stockholders’ equity	US$ in thousands	337,663	332,017	352,128	358,107	364,188	405,120	409,544	476,075	478,047	489,259	452,281	208,777	204,429	186,851	105,843	67,709	43,321	35,191	2,072	-3,740
ROE		-19.67%	-30.79%	-23.69%	-40.80%	-38.39%	-26.25%	-23.43%	-3.20%	-1.86%	0.82%	0.62%	-10.27%	0.97%	4.16%	18.12%	58.80%	-3.82%	46.30%	-890.01%	—

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-66,427K ÷ $337,663K
= -19.67%

The return on equity (ROE) for BioLife Solutions Inc has shown significant fluctuations over the past few quarters, ranging from -890.01% to 58.80%. The ROE has been negative in most recent quarters, indicating that the company's net income is not sufficient to generate a positive return for its shareholders.

The ROE has been particularly low in the last four quarters, with values below -20%, reaching as low as -40.80%. These results suggest that the company's profitability and efficiency in generating returns for its shareholders have been under pressure.

It is important for investors to closely monitor the company's financial performance and management strategies to assess its ability to improve ROE in the future. The negative and fluctuating ROE trends may raise concerns about the company's overall financial health and sustainability.